Isolated popliteal artery is defined as an obstruction of a superficial fem
oral artery with a patent popliteal segment followed by an obstructed dista
l popliteal artery or a patent leg artery less than 5 cm long.
Purpose: The aim of this retrospective study was to report the results of s
urgical treatment and the causes of failures.
Patients and methods: From 1988 to 1996, 31 patients with isolated poplitea
l artery were operated on with femoropopliteal bypass. The age of the patie
nts ranged from 45 to 92 years, (mean: 79 years); all had critical ischemia
that threatened limb viability. All underwent preoperative arteriography a
nd diagnosis was confirmed by intraoperative arteriography.
Results: In the postoperative course, there were 22 patent bypasses (68%) w
ith minor amputation in five patients, and nine thromboses that required a
major amputation in seven patients, a trans-metatarsal amputation in one, a
nd a medical treatment in one. With a mean 37-month follow-up, seven thromb
oses required a major amputation in five patients, a new bypass in one and
a medical treatment in one. The death rate was 34% at two years. The actuar
ial patency rates of the bypasses were 51% at one year, 38% at two years an
d 25% at five years. The limb salvage rate was identical. The patency rates
were 65% at one, two and five years for venous bypasses and 38%, 13% and 0
% respectively for PTFE bypasses. Statistical analysis showed two causes of
failure: the absence of a run-off branch and the use of PTFE prostheses. N
o other statistically significant cause of failure was demonstrated among t
hose analysed. Favourable anatomic conditions for a bypass to a leg artery
were not predictive of failure of a femoro-popliteal bypass on the isolated
arterial segment.
Conclusion: Bypass to isolated popliteal artery is indicated in patients wh
ose limb viability is jeopardized. Results may be considered as satisfactor
y especially if there is a run-off branch and if a venous graft is availabl
e for the bypass. (C) 2000 Editions scientifiques et medicales Elsevier SAS
.